| People with migraine (n = 19) | Healthy participants (n = 19) |
---|---|---|
Age in years | 47.3 (11.7) | 47.5 (11.8) |
Sex: female (%) | 16 (84.2%) | 16 (84.2%) |
Hand dominance: right (%) | 16 (84.2%) | 18 (94.7%) |
Years with migrainea | 30.0 (12.0–34.0) | N/A |
Migraine days/montha | 5.0 (4.0–10.0) | N/A |
Episodic migraine (%) | 14 (73.7%) | |
Chronic migraine (%) | 5 (23.3%) | |
Side of migraine (%) | ||
Dominantly left | 7 (36.8%) | N/A |
Dominantly right | 9 (47.4%) | |
Bilateral | 3 (15.8%) | |
Aura: yes (%) | 6 (31.6) | N/A |
Pain intensity (NPRS), interictal phasea | 0.0 (0.0–1.0) | 0.0 (0.0–0.0) |
Central Sensitization Inventory | 32.7 (11.1) | 20.0 (11.2)* |
Allodynia Symptom Checklist-12 items | 3.4 (2.4) | 0.6 (2.1)* |
Headache Impact Test-6 item | 62.3 (8.9) | 44.4 (10.2)* |
Pain medication (NSAIDs or paracetamol) used in last month: yes (%) | 12 (63.2%) | 0 |
Prophylactic medication used in the last month: yes (%) | 8 (42.1%) | 0 |
Beta-blockers | 7 (36.8%) | |
Antidepressants | 1 (5.3%) | |
Triptans used in last month: yes (%) | 16 (84.2%) | 0 |